The class of compounds identified as TPTE inhibitors encompasses a range of chemicals that can inhibit the TPTE protein, a phosphatase involved in cellular signaling and the dephosphorylation of specific substrates. These inhibitors are not a homogenous group but are instead characterized by their ability to interfere with the enzymatic activity of TPTE or its related signaling pathways. The action of these compounds can be direct, such as by binding to the active site of TPTE, or indirect, by modulating the cellular environment or the phosphorylation state of proteins that interact with TPTE. The mechanisms by which these compounds act can vary significantly, from mimicking the structure of the TPTE substrate to altering the structural integrity of the enzyme, or even by changing the localization and concentration of TPTE within the cell.
The study of TPTE inhibitors is rooted in the understanding of enzymology and signal transduction. These compounds are identified based on their structural characteristics and known biochemical activities, which can suggest a capacity to alter TPTE function. The identification process often involves screening for compounds that interact with the TPTE protein or its substrates and analyzing the resulting changes in enzymatic activity. Researchers also consider the broader impact of these compounds on cell signaling pathways, looking at how they can influence the phosphorylation patterns within the cell. The interaction of these inhibitors with TPTE can lead to changes in the enzyme's ability to bind or dephosphorylate its substrates, effectively modulating the protein's activity. The varied chemical nature of these inhibitors means that they can act on TPTE in numerous ways, allowing for a diverse set of tools to explore the function of TPTE and its role within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
Mimics the phosphate group and competes for binding at the phosphatase active site, which could possibly inhibit TPTE by preventing it from binding to its natural substrates. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts the structure and function of the Golgi apparatus, which could possibly affect the trafficking and localization of TPTE to the membrane, impacting its activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Although predominantly targeting serine/threonine phosphatases, it could possibly affect the phosphorylation state of cellular proteins, potentially influencing TPTE function. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $90.00 $251.00 | 5 | |
As a bisphosphonate, it could interfere with prenylation and thus could possibly affect signaling proteins that might regulate or interact with TPTE. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
As a tyrosine kinase inhibitor, it could lead to increased tyrosine phosphorylation levels, which could possibly affect the substrate availability or regulatory state of TPTE. | ||||||
Perphenazine | 58-39-9 | sc-208161 | 100 mg | $190.00 | ||
Affects multiple signaling pathways through its antagonistic effect on dopamine receptors, which could possibly modify the signaling environment of TPTE. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
By increasing intracellular cAMP, it may activate protein kinase A (PKA) and other cAMP-dependent processes that could possibly modulate TPTE function or expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Known to inhibit a wide array of kinases, it could alter the phosphorylation landscape in the cell, which could possibly affect TPTE's role in dephosphorylation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Primarily inhibits Src-family tyrosine kinases, which could possibly affect TPTE by altering upstream signaling or competitive substrate interactions. | ||||||